Cargando…

Preclinical evaluation of two (68)Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging

PURPOSE: Invasive pulmonary aspergillosis is mainly caused by Aspergillus fumigatus, and is one of the major causes of morbidity and mortality in immunocompromised patients. The mortality associated with invasive pulmonary aspergillosis remains high, mainly due to the difficulties and limitations in...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrik, Milos, Franssen, Gerben M., Haas, Hubertus, Laverman, Peter, Hörtnagl, Caroline, Schrettl, Markus, Helbok, Anna, Lass-Flörl, Cornelia, Decristoforo, Clemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369139/
https://www.ncbi.nlm.nih.gov/pubmed/22526953
http://dx.doi.org/10.1007/s00259-012-2110-3
_version_ 1782235028753743872
author Petrik, Milos
Franssen, Gerben M.
Haas, Hubertus
Laverman, Peter
Hörtnagl, Caroline
Schrettl, Markus
Helbok, Anna
Lass-Flörl, Cornelia
Decristoforo, Clemens
author_facet Petrik, Milos
Franssen, Gerben M.
Haas, Hubertus
Laverman, Peter
Hörtnagl, Caroline
Schrettl, Markus
Helbok, Anna
Lass-Flörl, Cornelia
Decristoforo, Clemens
author_sort Petrik, Milos
collection PubMed
description PURPOSE: Invasive pulmonary aspergillosis is mainly caused by Aspergillus fumigatus, and is one of the major causes of morbidity and mortality in immunocompromised patients. The mortality associated with invasive pulmonary aspergillosis remains high, mainly due to the difficulties and limitations in diagnosis. We have shown that siderophores can be labelled with (68)Ga and can be used for PET imaging of A. fumigatus infection in rats. Here we report on the further evaluation of the most promising (68)Ga-siderophore candidates, triacetylfusarinine (TAFC) and ferrioxamine E (FOXE). METHODS: Siderophores were labelled with (68)Ga using acetate buffer. Log P, protein binding and stability values were determined. Uptake by A. fumigatus was studied in vitro in cultures with high and low iron loads. In vivo biodistribution was determined in normal mice and an infection model was established using neutropenic rats inoculated with A. fumigatus. Static and dynamic μPET imaging was performed and correlated with CT images, and lung infection was evaluated ex vivo. RESULTS: (68)Ga-siderophores were labelled with high radiochemical purity and specific activity. (68)Ga-TAFC and (68)Ga-FOXE showed high uptake by A. fumigatus in iron-deficient cultures. In normal mice, (68)Ga-TAFC and (68)Ga-FOXE showed rapid renal excretion with high metabolic stability. In the rat infection model focal lung uptake was detected by μPET with both compounds and increased with severity of the infection, correlating with abnormal CT images. CONCLUSION: (68)Ga-TAFC and (68)Ga-FOXE displayed excellent in vitro stability and high uptake by A. fumigatus. Both compounds showed excellent pharmacokinetics, highly selective accumulation in infected lung tissue and good correlation with severity of disease in a rat infection model, which makes them promising agents for A. fumigatus infection imaging. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00259-012-2110-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3369139
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-33691392012-06-14 Preclinical evaluation of two (68)Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging Petrik, Milos Franssen, Gerben M. Haas, Hubertus Laverman, Peter Hörtnagl, Caroline Schrettl, Markus Helbok, Anna Lass-Flörl, Cornelia Decristoforo, Clemens Eur J Nucl Med Mol Imaging Original Article PURPOSE: Invasive pulmonary aspergillosis is mainly caused by Aspergillus fumigatus, and is one of the major causes of morbidity and mortality in immunocompromised patients. The mortality associated with invasive pulmonary aspergillosis remains high, mainly due to the difficulties and limitations in diagnosis. We have shown that siderophores can be labelled with (68)Ga and can be used for PET imaging of A. fumigatus infection in rats. Here we report on the further evaluation of the most promising (68)Ga-siderophore candidates, triacetylfusarinine (TAFC) and ferrioxamine E (FOXE). METHODS: Siderophores were labelled with (68)Ga using acetate buffer. Log P, protein binding and stability values were determined. Uptake by A. fumigatus was studied in vitro in cultures with high and low iron loads. In vivo biodistribution was determined in normal mice and an infection model was established using neutropenic rats inoculated with A. fumigatus. Static and dynamic μPET imaging was performed and correlated with CT images, and lung infection was evaluated ex vivo. RESULTS: (68)Ga-siderophores were labelled with high radiochemical purity and specific activity. (68)Ga-TAFC and (68)Ga-FOXE showed high uptake by A. fumigatus in iron-deficient cultures. In normal mice, (68)Ga-TAFC and (68)Ga-FOXE showed rapid renal excretion with high metabolic stability. In the rat infection model focal lung uptake was detected by μPET with both compounds and increased with severity of the infection, correlating with abnormal CT images. CONCLUSION: (68)Ga-TAFC and (68)Ga-FOXE displayed excellent in vitro stability and high uptake by A. fumigatus. Both compounds showed excellent pharmacokinetics, highly selective accumulation in infected lung tissue and good correlation with severity of disease in a rat infection model, which makes them promising agents for A. fumigatus infection imaging. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00259-012-2110-3) contains supplementary material, which is available to authorized users. Springer-Verlag 2012-04-24 2012 /pmc/articles/PMC3369139/ /pubmed/22526953 http://dx.doi.org/10.1007/s00259-012-2110-3 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Article
Petrik, Milos
Franssen, Gerben M.
Haas, Hubertus
Laverman, Peter
Hörtnagl, Caroline
Schrettl, Markus
Helbok, Anna
Lass-Flörl, Cornelia
Decristoforo, Clemens
Preclinical evaluation of two (68)Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging
title Preclinical evaluation of two (68)Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging
title_full Preclinical evaluation of two (68)Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging
title_fullStr Preclinical evaluation of two (68)Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging
title_full_unstemmed Preclinical evaluation of two (68)Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging
title_short Preclinical evaluation of two (68)Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging
title_sort preclinical evaluation of two (68)ga-siderophores as potential radiopharmaceuticals for aspergillus fumigatus infection imaging
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369139/
https://www.ncbi.nlm.nih.gov/pubmed/22526953
http://dx.doi.org/10.1007/s00259-012-2110-3
work_keys_str_mv AT petrikmilos preclinicalevaluationoftwo68gasiderophoresaspotentialradiopharmaceuticalsforaspergillusfumigatusinfectionimaging
AT franssengerbenm preclinicalevaluationoftwo68gasiderophoresaspotentialradiopharmaceuticalsforaspergillusfumigatusinfectionimaging
AT haashubertus preclinicalevaluationoftwo68gasiderophoresaspotentialradiopharmaceuticalsforaspergillusfumigatusinfectionimaging
AT lavermanpeter preclinicalevaluationoftwo68gasiderophoresaspotentialradiopharmaceuticalsforaspergillusfumigatusinfectionimaging
AT hortnaglcaroline preclinicalevaluationoftwo68gasiderophoresaspotentialradiopharmaceuticalsforaspergillusfumigatusinfectionimaging
AT schrettlmarkus preclinicalevaluationoftwo68gasiderophoresaspotentialradiopharmaceuticalsforaspergillusfumigatusinfectionimaging
AT helbokanna preclinicalevaluationoftwo68gasiderophoresaspotentialradiopharmaceuticalsforaspergillusfumigatusinfectionimaging
AT lassflorlcornelia preclinicalevaluationoftwo68gasiderophoresaspotentialradiopharmaceuticalsforaspergillusfumigatusinfectionimaging
AT decristoforoclemens preclinicalevaluationoftwo68gasiderophoresaspotentialradiopharmaceuticalsforaspergillusfumigatusinfectionimaging